CLINICAL SOLUTIONS
Eliminating the barriers between specialist care and the
patient. We provide hospital-grade echocardiography,
continuous monitoring, and diagnostic reporting directly to your clinic or community.
An ECHOCARDIOGRAM is a non-invasive diagnostic imaging service offered by The HeartScreen that uses ultrasound technology to create detailed images of the heart.
This test allows healthcare professionals to evaluate the heart’s structure and function in real time, including the heart chambers, valves, and blood flow. During the procedure, a trained technician places a small device called a transducer on the patient’s chest. The transducer emits sound waves that bounce off the heart and produce moving images on a monitor, helping assess how well the heart is pumping and if valves are working properly.
An echocardiogram is commonly used to help diagnose and monitor various heart conditions, including heart valve disease, heart failure, congenital heart defects, and cardiomyopathy. It can also detect blood clots, fluid around the heart, and abnormalities in the heart’s or structure.
THIS SAFE AND PAINLESS TEST PROVIDES VALUABLE INFORMATION THAT HELPS HEALTCARE PROFESSIONALS MAKE ACCURATE DIAGNOSES AND DEVELOP EFFECTIVE TREATMENT PLANS, SUPPORTING BETTER CARDIOVASCULAR HEALTH AND PATIENT CARE.
By integrating predictive Paroxysmal Atrial Fibrillation (PAF) detection into echocardiography screening, The HeartScreen plays a vital role in improving heart health outcomes for First Nations communities Australia.
Higher Prevalence of Cardiovascular Disease: First Nations Australians experience disproportionately higher rates of cardiovascular diseases, including atrial fibrillation (AF), compared to non-Indigenous populations. Early detection of PAF can help prevent progression to permanent AF, reducing the risk of stroke and other complications.
Remote and Rural Access: Many First Nations communities live in remote areas with limited access to specialised healthcare services. By integrating PAF prediction into echocardiography screening, your business can provide a mobile or community-based solution that brings advanced heart health technology directly to these communities.
Preventing Stroke and Heart Failure: PAF is a precursor to permanent AF, which significantly increases the risk of stroke and heart failure. Early detection and management can reduce these risks, improving life expectancy and quality of life for First Nations individuals.
Community Engagement: Your business can work with First Nations leaders and healthcare providers to ensure the screening process is culturally sensitive and tailored to the needs of the community.
Improving Health Equity: This initiative aligns with the Australian government’s “Closing the Gap” strategy, which aims to reduce health disparities between First Nations and non-Indigenous Australians. By providing advanced screening and predictive analytics, your business can contribute to this national goal.
Empowering Communities: Offering advanced screening services can empower First Nations individuals to take control of their heart health, fostering trust in healthcare providers and systems.
Data Collection for Research: Implementing this screening process in First Nations communities can generate valuable data to better understand the prevalence and triggers of PAF in these populations, leading to more targeted interventions.
Mobile Screening Units: Deploy mobile echocardiography and HRV screening units to remote areas, ensuring accessibility for communities with limited healthcare infrastructure.
Government Grants: Apply for funding through Australian government programs aimed at improving First Nations health, such as the Indigenous Australians’ Health Program (IAHP).
By integrating predictive PAF detection into echocardiography screening The HeartScreen, can play a vital role in improving heart health outcomes for First Nations communities in Australia. This initiative aligns with national health priorities, addresses critical health disparities, and provides a sustainable, culturally sensitive solution to prevent cardiovascular complications.
24-Hour Blood Pressure Monitoring (also called Ambulatory Blood Pressure Monitoring – ABPM) is a diagnostic test offered by The HeartScreen to continuously measure a patient’s blood pressure over a full 24-hour period while they go about their normal daily activities and sleep.
This service involves wearing a small portable blood pressure monitor connected to a cuff placed around the upper arm. The device automatically measures and records blood pressure at regular intervals usually every 15-30 minutes during the day ad every 30-60 minutes at night
This test allows doctors to observe how blood pressure changes throughout a 24-hour cycle in real-life conditions. The collected data is later analysed to provide a detailed report on blood pressure patterns overall cadiovascular health.
A Holter monitor is a small, portable device that records heart electrical activity (ECG) continuously over 24 to 48 hours (or up to 7 days). It captures rhythm changes during normal activity and sleep to investigate symptoms such as dizziness, palpitations, chest discomfort, or shortness of breath.
SLEEP APNEA SCREENING is a diagnostic service offered by The HeartScreen to help identify individuals who may be suffering from sleep apnea, a common sleep disorder in which breathing repeatedly stops and starts during sleep.
This condition can significantly impact overall health and is often associated with increased risks of high blood pressure, heart disease, stroke, and fatigue.
During the screening process, patients undergo a sleep assessment or home sleep test using specialised monitoring equipment. The device records important data while the patient sleeps, such as breathing patters, oxygen level, heart rate, and body movements. this information helps healthcare professionals determine whether sleep apnea other or other sleep-related breathing disorders are present.
Screening is especially recommended for individuals who experience:
ECG REPORTING is a diagnostic service that involves the professional analysis and interpretation of an electrocardiogram (ECG) test. An ECG records the electrical activity of the heart and helps evaluate heart rhythm, rate, and overall cardiac function.
During the test, small sensors called electrodes are placed on the patient’s chest, arms, and legs to capture the heart’s electrical signals. These signals are displayed as wave patterns on a monitor or printed report. Through ECG reporting, trained medical professionals review and interpret these recordings to identify any abnormalities.
This service helps detect a range of heart conditions, including irregular heart rhythms (arrhythmias), heart attacks, heart enlargement, and structural abnormalities. It also assists doctors in monitoring heart health, evaluating symptoms like palpitations or shortness of breath, and assessing treatment effectiveness.
Heart disease remans Australia’s leading cause of death, yet cases often develop silently. Our pilot demonstrated that OVER 22% of asymptomatic participants presented with abnormalities detectable only via echocardiography.
Routine access catches silent disease early, reduces avoidable hospital mortality and aligns with Australia’s Preventive Health Strategy 2021-2030.